콘텐츠로 건너뛰기
Merck
  • Granzyme B gene polymorphism associated with subacute sclerosing panencephalitis.

Granzyme B gene polymorphism associated with subacute sclerosing panencephalitis.

Neuropediatrics (2014-05-31)
Sibel P Yentur, Hatice Nur Aydin, Candan Gurses, Veysi Demirbilek, Umit Kuru, Serap Uysal, Zuhal Yapici, Safa Baris, Gülden Yilmaz, Ozlem Cokar, Emel Onal, Ayşen Gokyigit, Güher Saruhan-Direskeneli
초록

Subacute sclerosing panencephalitis (SSPE) is a late complication of measles infection. Immune dysfunction related to genetic susceptibility has been considered in disease pathogenesis. A functional single nucleotide polymorphism (SNP) of granzyme B gene (GZMB) reported in several pathologies may also be involved in susceptibility to SSPE. An SNP (rs8192917, G → A, R→Q) was screened in 118 SSPE patients and 221 healthy controls (HC) by polymerase chain reaction-restriction fragment length polymorphism. Frequencies were compared between groups. In vitro production of GZMB was measured in controls with different genotypes. The SNP had a minor allele (G) frequency of 0.22 in patients and 0.31 in controls. GG genotype was significantly less frequent in patients (odds ratio, 0.23). G allele carriers produced relatively higher levels of GZMB, when stimulated in vitro. These findings implicate possible effect of this genetic polymorphism in susceptibility to SSPE which needs to be confirmed in bigger populations.